<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
73648-154-04
</NDCCode>
<PackageDescription>
4 VIAL, PLASTIC in 1 CARTON (73648-154-04) / 3.8 mL in 1 VIAL, PLASTIC
</PackageDescription>
<NDC11Code>
73648-0154-04
</NDC11Code>
<ProductNDC>
73648-154
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ryoncil
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Remestemcel-l-rknd
</NonProprietaryName>
<DosageFormName>
SUSPENSION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20241218
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA125706
</ApplicationNumber>
<LabelerName>
Mesoblast
</LabelerName>
<SubstanceName>
ALLOGENIC BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS
</SubstanceName>
<StrengthNumber>
6680000
</StrengthNumber>
<StrengthUnit>
[arb'U]/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-03-04
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20241218
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>